Instagram
youtube
Facebook

Associate Medical Reviewer

1-2 years
Not Disclosed
10 July 24, 2025
Job Description
Job Type: Hybrid Education: MBBS/MD Skills: Causality Assessment, Clinical SAS Programming, Communication Skills, CPC Certified, GCP guidelines, ICD-10 CM Codes, CPT-Codes, HCPCS Codes, ICD-10 CM, CPT, HCPCS Coding, ICH guidelines, ICSR Case Processing, Interpersonal Skill, Labelling Assessment, MedDRA Coding, Medical Billing, Medical Coding, Medical Terminology, Narrative Writing, Research & Development, Technical Skill, Triage of ICSRs, WHO DD Coding

 

Associate Medical Reviewer – Centralised Monitoring Unit (CMU)

Company: Novo Nordisk
Location: Bangalore, Karnataka, India
Category: Clinical Development
Application Deadline: 31 July 2025
Work Mode: On-site / Hybrid (CMU Bangalore)
Compensation / Salary: Not disclosed in the job description

Job Summary

Novo Nordisk’s Centralised Monitoring Unit (CMU) in Bangalore is hiring an Associate Medical Reviewer to perform risk‑based medical monitoring and comprehensive medical data reviews across multiple therapy areas. You will safeguard patient safety, protocol adherence, ICH‑GCP compliance, and clinical data quality by partnering closely with data managers, trial managers and medical specialists. Note: This is not a Pharmacovigilance role.


Key Responsibilities

  • Perform end‑to‑end medical review of clinical trial data ensuring protocol compliance, patient safety and data integrity.

  • Contribute to trial planning activities related to medical review; perform quality checks for the review process.

  • Identify, clarify, and resolve medically significant issues/outliers with investigational sites.

  • Present medical review findings to Medical Specialists for decision‑making and document reviews in the TMF.

  • Collaborate closely with Data Managers, Trial Managers, and Medical Specialists; train new team members on processes and projects.

  • Review and provide inputs to the Medical Monitoring Plan (MMP) and medical monitoring displays/listings to ensure efficient review.

  • Ensure compliance with ICH‑GCP, local regulations, SOPs and trial-specific requirements.

  • Provide status updates, escalate issues, and support continuous improvement within centralized/risk-based monitoring frameworks.


Required Skills & Qualifications

  • MBBS/MD (Medicine or other clinical specialties) with relevant clinical patient management or clinical research experience.

  • ≥1 year of experience in Clinical Drug Development (e.g., Medical Data Review, Medical Monitoring, Safety Surveillance, Investigator role, Scientific Clinical Development).

  • 1–2 years of project management experience (essential).

  • Solid understanding of ICH guidelines, Good Clinical Practice (GCP) and clinical trial operations.

  • Proficiency with MS Office, MS Project, PowerPoint; ability to interpret complex clinical datasets.

  • Excellent medical terminology knowledge, analytical/problem‑solving ability, and strong written & spoken English.


Perks & Benefits

  • Opportunity to work within a global, high-impact CMU alongside expert medical and statistical monitors.

  • Career development & progression, technical/therapeutic training, and a Total Self culture promoting diversity & inclusion.

  • Be part of a 100‑year legacy organisation impacting 40M+ patients daily worldwide.


Company Description (SEO-rich)

Novo Nordisk is a global healthcare leader focused on defeating serious chronic diseases. With 72,000+ employees worldwide and a relentless commitment to innovation, patient safety, and data quality, Novo Nordisk drives impactful change across diabetes, obesity, and other chronic diseases, advancing life-changing therapies through cutting-edge clinical drug development.


Work Mode

On-site / Hybrid – Bangalore, India (CMU).


Call-to-Action

Ready to elevate patient safety and data quality across global trials? Apply now for the Associate Medical Reviewer role at Novo Nordisk before 31 July 2025 and help shape clinical excellence through centralized, risk-based monitoring.